Date: 25th November, 2022

To,

The Manager,

Listing Department,

National Stock Exchange of India Limited

"Exchange Plaza"

Bandra Kurla Complex, Bandra (E)

Mumbai - 400 051

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Analyst / Investor Meeting

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company shall be meeting analysts/investors through NBIE Virtual Investor Meeting hosted by Nirmal Bang Institutional Equities on 25th November, 2022.

We request you to kindly take the same on record.

Thanking you,

Yours faithfully,

For Alembic Pharmaceuticals Limited

CHARANDEEP SINGH SALUJA

Digitally signed by CHARANDEEP SINGH SALUJA DN: c=IN, o=Personal, pseudonym=a60bda6662cacaa6dee424354752c8af2 17d06e3e0b6cc73c4bb1acdf09b43c5, postalCode=390008, st=GUJARAT, serialNumber=2df2425a9d726770b96178ea7d183d3 b13c8557e9c4be4aaf90236628eb533e7, cn=CHARANDEEP SINGH SALUJA

Date: 2022.11.25 10:21:24 +05'30'

Charandeep Singh Saluja

Company Secretary

ALEMBIC PHARMACEUTICALS LIMITED

REGD. OFFICE : ALEMBIC ROAD, VADODARA - 390 003. ● TEL : (0265) 2280550, 2280880 ● FAX : (0265) 2281229

Website : www.alembicpharmaceuticals.com ● E-mail :alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Alembic Pharmaceuticals Limited published this content on 25 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 November 2022 05:33:10 UTC.